Created in 2015 (United States), JUNIPER PHARMA own 17 sister brands and 4958 competing brands. JUNIPER PHARMA is owned by Catalent, listed on the stock exchange of New York The sector of JUNIPER PHARMA is Drug Manufacturers.
Share price and profitability of the share Catalent (JUNIPER PHARMA)
Buy Catalent share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Catalent
(JUNIPER PHARMA)
over 5 years*
USD 69.71
Stock market history Catalent (JUNIPER PHARMA)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
